PRMT5 and glioblastoma: PRMT5 is overexpressed in a number of cancers including melanoma, multiple myeloma, glioblastoma, lung, gastric, prostate, ovarian, and colorectal cancers,6 and high expression of PRMT5 often correlates with poor patient prognosis.6